Azenta, Inc. (AZTA) vs Sarepta Therapeutics, Inc. (SRPT)
A side-by-side comparison of Azenta, Inc. and Sarepta Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AZTA
Azenta, Inc.
$40.16HealthcareDelayed quote: Oct 6, 2026, 2:50 PM EDT
SRPT
Sarepta Therapeutics, Inc.
$17.28HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT
Total return — AZTA vs SRPT
growth of $100 · dividends reinvested · last 10yAZTA +234.8% (+12.8%/yr)SRPT -67.4% (-10.6%/yr)AZTA compounded faster over this window
Log scale — wide-divergence pair
AZTA SRPT
AZTA vs SRPT: by the numbers
- •AZTA is the larger company ($1.85B vs $1.82B market cap).
- •Both run net losses; SRPT's is the smaller (-6.93% vs -20.02% net margin).
- •SRPT grew revenue faster over the past five years (26.90% vs 4.82% CAGR).
Metrics side by side
Valuation
| Metric | AZTA | SRPT |
|---|---|---|
| Forward P/E | 80.86 | 5.37 |
| P/S ratio | 3.02 | 0.92 |
| P/B ratio | 1.23 | 1.19 |
| EV / EBITDA | 50.10 | N/A |
| FCF yield | 0.53% | N/A |
Profitability
| Metric | AZTA | SRPT |
|---|---|---|
| Gross margin | 44.05% | 58.56% |
| Operating margin | -3.49% | -29.92% |
| Net margin | -20.02% | -6.93% |
| ROE | -8.14% | -8.95% |
| ROIC | -1.33% | -5.33% |
Growth (annualized)
| Metric | AZTA | SRPT |
|---|---|---|
| Revenue CAGR (5Y) | 4.82% | 26.90% |
| Total return CAGR (5Y) | -15.91% | -28.74% |
Frequently asked
- Which has grown faster, AZTA or SRPT?
- Over the past five years, SRPT grew revenue faster — AZTA at a 4.82% CAGR versus SRPT at 26.90%.
- How have AZTA and SRPT total returns compared?
- Over the past 10 years, AZTA delivered 12.81% and SRPT delivered -11.94% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Azenta ROESarepta Therapeutics ROEAzenta operating marginSarepta Therapeutics operating marginAzenta revenue growthSarepta Therapeutics revenue growthAzenta free cash flowSarepta Therapeutics free cash flow
Azenta & Sarepta Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.